Medtronic pursues better economic health by moving principle offices from U.S. to Ireland

Published



Medical device giant Medtronic is now the largest firm to renounce its U.S. tax status as it legally moves operations to Ireland, where taxes are more business-friendly.

The move is part of Medtronic’s acquisition of Covidien, a rival health care and medical supply provider, for approximately $42.9 billion in cash and stock, according to a Medtronic press release.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.